Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tranexamic Acid
Intracerebral Hemorrhage
Christian Medical College and Hospital, Ludhiana, India
P4
BB
(66)
Trastuzumab
Metastatic Malignant Neoplasm In The Brain
Iambic Therapeutics, Inc
P4
BB
(66)
Trastuzumab Deruxtecan
Breast Cancer
SWOG Cancer Research Network
P4
BB
(66)
Trastuzumab Emtansine
HER2 Positive Breast Carcinoma
SWOG Cancer Research Network
P4
BB
(66)
Trazodone
Sleep Disorder
Johns Hopkins University
P4
BB
(66)
Trilaciclib
Small Cell Lung Carcinoma
Pharmacosmos A/S
P4
BB
(66)
Tucidinostat
Breast Cancer
Beijing 302 Hospital
P4
BB
(66)
Ublituximab
Relapsing-Remitting Multiple Sclerosis
TG Therapeutics, Inc.
P4
BB
(66)
Umbellatine
Inherited Lipid Metabolism Disorder
China National Center for Cardiovascular Diseases
P4
BB
(66)
Umbellatine
Metabolic Dysfunction-Associated Steatotic Liver Disease
China National Center for Cardiovascular Diseases
P4
BB
(66)
Varenicline
Schizophrenia
University of California, San Diego
P4
BB
(66)
VENLOR
Bipolar Disorder
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
P4
BB
(66)
VENLOR
Breast Cancer
University of Illinois at Chicago
P4
BB
(66)
(+)-Vincristine
ALK-Negative Anaplastic Large Cell Lymphoma
Shanghai Jiao Tong University School of Medicine
P4
BB
(66)
(+)-Vincristine
Angioimmunoblastic T-Cell Lymphoma
Shanghai Jiao Tong University School of Medicine
P4
BB
(66)
(+)-Vincristine
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.
P4
BB
(66)
Vortioxetine
Bipolar Depression
Mayo Clinic
P4
BB
(66)
Zinc D-Gluconate (1:2)
Wilson Disease
Jun Li
P4
BB
(66)
Zoster Vaccine Recombinant, Adjuvanted
Herpes Zoster
GlaxoSmithKline
P4
BB
(66)
4,5,7,4',5',7'-HEXAHYDROXY-2,2'-DIMETHYLNAPHTHODIANTHRONE
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Soligenix
P3
BB
(66)
Adebrelimab
Non-Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute
P3
BB
(66)
Adriamycin
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)
P3
BB
(66)
Adriamycin
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
Adriamycin
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
BB
(66)
Adriamycin
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(66)
Showing 2076 to 2100 of 42,301 assets
Previous
Page 84 of 1693
Next